Drugs and Therapeutics (D & T) Committee Meeting Results for: September 23, 2009
Drug Name | Review Type | Committee Recommendation | Prior Approval Status � Final Determination |
---|---|---|---|
Besivance | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Nascobal | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Santyl Ointment | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Toviaz | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Momexin | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Nucynta | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Bromfed DM | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Invega Sustenna | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Savella | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Multaq | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Saprhis | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Adcirca | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Onglyza | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Ulesfia | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Moxatag | New Drug Appeal | Removed from Agenda | Prior Approval Required |
PegIntron | PDL Appeal | Require Prior Approval | Prior Approval Required |
Advair | PDL Appeal | Remove Prior Approval Requirement | Prior Approval Requirement Removed |